Cognipride MV 2mg/500mg/0.2mg Tablet
Marketer
Cognitive Life Sciences Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Cognipride MV 2mg/500mg/0.2mg Tablet
Diabetol-Triple 2mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combination therapy is indicated for adult patients with type 2 diabetes mellitus to manage blood glucose. Diabetol-Triple should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Prompt glucose intake (e.g., sugary foods or juice) is essential. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Cognipride MV 2mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Cognipride MV 2mg/500mg/0.2mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Cognipride MV 2mg/500mg/0.2mg tablets on an empty stomach.
Common Side effects of Cognipride MV 2mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Cognipride MV 2mg/500mg/0.2mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. The tablet should be swallowed whole; do not chew, crush, or fracture it. Ingest Cognipride MV 2mg/500mg/0.2mg Tablet on an empty stomach.
How Cognipride MV 2mg/500mg/0.2mg Tablet works:
Tri-action diabetic medication Cognipride MV tablets (2mg/500mg/0.2mg) combine three antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Cognipride MV 2mg/500mg/0.2mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Cognipride MV 2mg/500mg/0.2mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Consult your physician for guidance.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Cognipride MV 2mg/500mg/0.2mg tablets is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
Employing Cognipride MV 2mg/500mg/0.2mg tablets in individuals with kidney impairment poses a likely risk and is best avoided. Medical advice is recommended. Furthermore, its use is discouraged for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Cognipride MV 2mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, the medication is unsuitable for individuals with severe hepatic dysfunction.
What if you forget to take Cognipride MV 2mg/500mg/0.2mg Tablet :
Should you forget to take your Cognipride MV 2mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount at one time.
Facts to Know About Cognipride MV 2mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently